Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine to prevent orthostatic hypotension after fast-track hip arthroplasty
2012-002572-13Phase 3Completed
- Sponsor
- Henrik Kehlet
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in orthostatic hypotension (OH) and orthostatic intolerance comparing Midodrine 5 mg with Placebo (2 arms). Primary endpoint: Incidence of orthostatic hypotension at 6 hours post-surgery. Started Jul 2012; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)orthostatic intolerance
Beyond the preview
Go deeper on 2012-002572-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002572-13.